Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF.

Liver sinusoidal endothelial cells (LSECs) represent a highly differentiated cell type that lines hepatic sinusoids. LSECs form a discontinuous endothelium due to fenestrations under physiological conditions, which are reduced upon chronic liver injury. Cultivation of rodent LSECs associates with a...

Full description

Bibliographic Details
Main Authors: Petra Koudelkova, Gerhard Weber, Wolfgang Mikulits
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC4631446?pdf=render
id doaj-712729bc2a4c4ab7a9febd4fadf9af30
record_format Article
spelling doaj-712729bc2a4c4ab7a9febd4fadf9af302020-11-25T00:20:23ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011011e014213410.1371/journal.pone.0142134Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF.Petra KoudelkovaGerhard WeberWolfgang MikulitsLiver sinusoidal endothelial cells (LSECs) represent a highly differentiated cell type that lines hepatic sinusoids. LSECs form a discontinuous endothelium due to fenestrations under physiological conditions, which are reduced upon chronic liver injury. Cultivation of rodent LSECs associates with a rapid onset of stress-induced senescence a few days post isolation, which limits genetic and biochemical studies ex vivo. Here we show the establishment of LSECs isolated from p19ARF-/- mice which undergo more than 50 cell doublings in the absence of senescence. Isolated p19ARF-/- LSECs display a cobblestone-like morphology and show the ability of tube formation. Analysis of DNA content revealed a stable diploid phenotype after long-term passaging without a gain of aneuploidy. Notably, p19ARF-/- LSECs express the endothelial markers CD31, vascular endothelial growth factor receptor (VEGFR)-2, VE-cadherin, von Willebrand factor, stabilin-2 and CD146 suggesting that these cells harbor and maintain an endothelial phenotype. In line, treatment with small molecule inhibitors against VEGFR-2 caused cell death, demonstrating the sustained ability of p19ARF-/- LSECs to respond to anti-angiogenic therapeutics. From these data we conclude that loss of p19ARF overcomes senescence of LSECs, allowing immortalization of cells without losing endothelial characteristics. Thus, p19ARF-/- LSECs provide a novel cellular model to study endothelial cell biology.http://europepmc.org/articles/PMC4631446?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Petra Koudelkova
Gerhard Weber
Wolfgang Mikulits
spellingShingle Petra Koudelkova
Gerhard Weber
Wolfgang Mikulits
Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF.
PLoS ONE
author_facet Petra Koudelkova
Gerhard Weber
Wolfgang Mikulits
author_sort Petra Koudelkova
title Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF.
title_short Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF.
title_full Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF.
title_fullStr Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF.
title_full_unstemmed Liver Sinusoidal Endothelial Cells Escape Senescence by Loss of p19ARF.
title_sort liver sinusoidal endothelial cells escape senescence by loss of p19arf.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2015-01-01
description Liver sinusoidal endothelial cells (LSECs) represent a highly differentiated cell type that lines hepatic sinusoids. LSECs form a discontinuous endothelium due to fenestrations under physiological conditions, which are reduced upon chronic liver injury. Cultivation of rodent LSECs associates with a rapid onset of stress-induced senescence a few days post isolation, which limits genetic and biochemical studies ex vivo. Here we show the establishment of LSECs isolated from p19ARF-/- mice which undergo more than 50 cell doublings in the absence of senescence. Isolated p19ARF-/- LSECs display a cobblestone-like morphology and show the ability of tube formation. Analysis of DNA content revealed a stable diploid phenotype after long-term passaging without a gain of aneuploidy. Notably, p19ARF-/- LSECs express the endothelial markers CD31, vascular endothelial growth factor receptor (VEGFR)-2, VE-cadherin, von Willebrand factor, stabilin-2 and CD146 suggesting that these cells harbor and maintain an endothelial phenotype. In line, treatment with small molecule inhibitors against VEGFR-2 caused cell death, demonstrating the sustained ability of p19ARF-/- LSECs to respond to anti-angiogenic therapeutics. From these data we conclude that loss of p19ARF overcomes senescence of LSECs, allowing immortalization of cells without losing endothelial characteristics. Thus, p19ARF-/- LSECs provide a novel cellular model to study endothelial cell biology.
url http://europepmc.org/articles/PMC4631446?pdf=render
work_keys_str_mv AT petrakoudelkova liversinusoidalendothelialcellsescapesenescencebylossofp19arf
AT gerhardweber liversinusoidalendothelialcellsescapesenescencebylossofp19arf
AT wolfgangmikulits liversinusoidalendothelialcellsescapesenescencebylossofp19arf
_version_ 1725368033623408640